SCHEMBL482904

SCHEMBL482904

Cc1c(C)n(C)c2c1ccc1ccccc12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.47
▸ KDM4E B2RXH2 5/20 0.47
▸ MAPK1 P28482 2/20 0.47
▸ GAA P10253 1/20 0.47
▸ TSHR P16473 3/20 0.46
▸ HSD17B10 Q99714 3/20 0.46
▸ HPGD P15428 3/20 0.46
▸ CYP3A4 P08684 2/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ HIF1A Q16665 2/20 0.46
▸ CASP1 P29466 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ CASP7 P55210 1/20 0.46
▸ ATM Q13315 1/20 0.46
▸ CYP2A6 P11509 3/20 0.45
▸ CYP1A2 P05177 2/20 0.45
▸ PRNP P04156 1/20 0.45
▸ HPRT1 P00492 1/20 0.43
▸ TDP1 Q9NUW8 2/20 0.41
▸ MAPT P10636 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12258291 0.81 HPRT1 (0.52) ALDH1A1KDM4EMAPK1TSHRHSD17B10
SCHEMBL17486933 0.76 CYP2A6 (0.52) ALDH1A1KDM4EMAPK1GAATSHR
SCHEMBL257568 0.74 ALKBH5 (0.58) ALDH1A1KDM4EGAATSHRHSD17B10
SCHEMBL4422822 0.74 HPGD (0.44) ALDH1A1KDM4EMAPK1TSHRHSD17B10
SCHEMBL30583770 0.74 ALKBH5 (0.57) ALDH1A1KDM4EMAPK1GAARAB9A
SCHEMBL17521790 0.73 PRNP (0.45) ALDH1A1KDM4EMAPK1TSHRHSD17B10
SCHEMBL1920722 0.72 HPGD (0.48) ALDH1A1KDM4EMAPK1GAATSHR
SCHEMBL17521818 0.72 PRNP (0.44) ALDH1A1KDM4EMAPK1TSHRHSD17B10
SCHEMBL2604387 0.72 TSHR (0.44) ALDH1A1KDM4EMAPK1TSHRHSD17B10
SCHEMBL31756961 0.72 HPGD (0.48) ALDH1A1KDM4EMAPK1GAATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1772282-B1 OPTICAL RECORDING MATERIAL AND OPTICAL RECORDING MEDIUM ADEKA CORP (JP) 2012-02-01 — — EP disclosed
US-20100080947-A1 OPTICAL RECORDING MEDIUM ADEKA CORPORATION (JP) 2010-04-01 — — US disclosed
US-7674569-B2 Optical recording material and optical recording medium ADEKA CORPORATION (JP) 2010-03-09 — — US disclosed
US-20080033179-A1 Optical Recording Material and Optical Recording Medium ADEKA CORPORATION (JP) 2008-02-07 — — US disclosed
EP-1772282-A1 OPTICAL RECORDING MATERIAL AND OPTICAL RECORDING MEDIUM Adeka Corporation (JP) 2007-04-11 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080033179-A1 Optical Recording Material and Optical Recording Medium OR10J3, HCN3, CHRM4 ALDH1A1 3777/4885KDM4E 1653/4885MAPK1 543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback